ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALLEN SUSSMAN MD

Endocrinology, Diabetes Metabolism

5,632

$636K

339
288 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 45%

$113
Average prescription price

Avg: $130

RODNEY SKOGLUND MD

Endocrinology, Diabetes Metabolism

5,618

$437K

342
308 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 45%

$78
Average prescription price

Avg: $130

KARL MCCOWEN MD

Endocrinology, Diabetes Metabolism

5,561

$660K

372
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 45%

$119
Average prescription price

Avg: $130

DAVID TURK M.D.

Endocrinology, Diabetes Metabolism

5,077

$651K

441
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 45%

$128
Average prescription price

Avg: $130

RONALD GRAF M.D.

Endocrinology, Diabetes Metabolism

4,896

$869K

452
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 45%

$177
Average prescription price

Avg: $130

ROBERT MURRAY M.D.

Endocrinology, Diabetes Metabolism

4,711

$347K

526
411 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 45%

$74
Average prescription price

Avg: $130

JEFFREY HARTMAN MD

Endocrinology, Diabetes Metabolism

4,576

$533K

202
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 45%

$116
Average prescription price

Avg: $130

JACK BIRNBAUM M.D.

Endocrinology, Diabetes Metabolism

4,497

$485K

263
210 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 45%

$108
Average prescription price

Avg: $130

RAMONA PUNGAN MD

Endocrinology, Diabetes Metabolism

4,475

$641K

285
228 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 45%

$143
Average prescription price

Avg: $130

ANTHONY OKOS

Endocrinology, Diabetes Metabolism

4,097

$274K

92
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 45%

$67
Average prescription price

Avg: $130

DALI CHEN MD, PHD

Endocrinology, Diabetes Metabolism

4,093

$581K

433
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 45%

$142
Average prescription price

Avg: $130

ERIC FRANKENFELD M.D.

Endocrinology, Diabetes Metabolism

3,912

$410K

307
218 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 45%

$105
Average prescription price

Avg: $130

MIHAELA COSMA M.D.

Endocrinology, Diabetes Metabolism

3,887

$801K

457
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 45%

$206
Average prescription price

Avg: $130

GARY ENZMANN MD

Endocrinology, Diabetes Metabolism

3,871

$356K

365
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 45%

$92
Average prescription price

Avg: $130

NANCY PURCELL MD

Endocrinology, Diabetes Metabolism

3,748

$249K

248
199 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 45%

$67
Average prescription price

Avg: $130

CAROL WYSHAM MD

Endocrinology, Diabetes Metabolism

3,737

$431K

285
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 45%

$115
Average prescription price

Avg: $130

NALINI SINGH M.D.

Endocrinology, Diabetes Metabolism

3,690

$395K

258
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 45%

$107
Average prescription price

Avg: $130

GHOLAM MOZAFFARIAN M.D., F.A.C.P.

Endocrinology, Diabetes Metabolism

3,634

$202K

193
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 45%

$56
Average prescription price

Avg: $130

MATTHEW DAVIES MD

Endocrinology, Diabetes Metabolism

3,601

$344K

402
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 45%

$95
Average prescription price

Avg: $130

GEORGE MOORE MD

Endocrinology, Diabetes Metabolism

3,472

$462K

331
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 45%

$133
Average prescription price

Avg: $130

NANCY NILES M.D.

Endocrinology, Diabetes Metabolism

3,409

$392K

190
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 45%

$115
Average prescription price

Avg: $130

LARRY STONESIFER MD

Endocrinology, Diabetes Metabolism

3,357

$429K

268
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 45%

$128
Average prescription price

Avg: $130

ROBERT KANTER M.D.

Endocrinology, Diabetes Metabolism

3,314

$387K

251
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 45%

$117
Average prescription price

Avg: $130

BRUCE WILSON M.D.

Endocrinology, Diabetes Metabolism

3,274

$570K

395
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 45%

$174
Average prescription price

Avg: $130

EDWARD LA CAVA MD

Endocrinology, Diabetes Metabolism

3,103

$541K

254
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 45%

$174
Average prescription price

Avg: $130

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank